In Zambia, ICAP is partnering with the Ministry of Health (MOH) to provide technical support in HIV prevention, care, and treatment programs. ICAP also supports the MOH in testing innovative service delivery models to achieve the 95-95-95 goals. ICAP’s work in Zambia includes supporting a sustainable surveillance system to improve HIV-related services for key populations and scaling up the screening and management of advanced HIV disease in Zambia’s Western and Southern provinces.
The CQUIN Project for Differentiated Service Delivery
ICAP in Zambia
Key Technical Areas
Capacity Building of Health Workforce
HIV Care and Treatment
Maternal and Child Health / PMTCT
- Bill & Melinda Gates Foundation
- PEPFAR / Centers for Disease Control and Prevention (CDC)/Health Resources & Services Administration (HRSA)
- Global Fund
Tafadzwa Dzinamarira, MSc, MPH, PhD
Dr. Dzinamarira is ICAP’s country director in Zambia. He is a public health expert with a solid clinical and epidemiological research background. He has over seven years of experience providing technical support for public health systems and clinical laboratories, strengthening the management of HIV/AIDS programs. Dr. Dzinamarira has expertise in providing technical leadership in developing, developing, planning, and implementing national household-based biomarker surveys. He holds a Master of Science in HIV/AIDS Management, a Master of Public Health (Disease Prevention and Control), and a Doctor of Philosophy in Public Health Medicine. Before this role, Dr. Dzinamarira was the Country Director for ICAP in Zimbabwe. Before that, he was the Regional Laboratory Technical Advisor for the PHIA project, where he successfully supported the implementation of national HIV impact assessment surveys in Namibia, Rwanda, Haiti, Eswatini, Lesotho, Malawi, Mozambique, Uganda, Tanzania, and Zimbabwe. Before joining ICAP, Dr. Dzinamarira worked for the University of Zimbabwe Department of Medicine on a prospective operation research series aimed at decreasing mortality by initiating antiretroviral therapy in Africa through early detection and prevention of cryptococcal disease in Zimbabwe.